cetirizine has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (16.67) | 18.7374 |
| 1990's | 13 (72.22) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cordeiro, RS; e Silva, PM; Martins, MA; Pasquale, CP; Pires, AL; Rihoux, JP; Ruffié, C; Vargaftig, BB | 1 |
| Cordeiro, RS; Diaz, BL; e Silva, PM; Lima, MC; Martins, MA; Pasquale, CP; Rihoux, JP; Vargaftig, BB | 1 |
| Rihoux, JP | 1 |
| Coyle, AJ; Lefort, J; Vargaftig, BB | 1 |
| Hartnell, A; Kay, AB; Moqbel, R; Walsh, GM | 1 |
| Fadel, R; Juhlin, L; Rihoux, JP | 1 |
| Juhlin, L; Rihoux, JP | 1 |
| Borgnon, A; David, B; Fadel, R; Herpin-Richard, N; Rassemont, R; Rihoux, JP | 1 |
| Juhlin, L | 1 |
| Capron, A; Capron, M; De Vos, C; Joseph, M; Leprevost, C; Tomassini, M; Vorng, H | 1 |
| Benveniste, J; Burtin, C; De Vos, C; Dubertret, L; Michel, L; Rihoux, JP | 1 |
| Capron, A; Capron, M; De Vos, C; Leprevost, C; Tomassini, M | 1 |
| Meltzer, EO | 1 |
| Leduc, D; Pretolani, M; Vargaftig, BB; Zuany-Amorim, C | 1 |
| De Vos, C; Ghosh, SK; Patel, KR; Rafferty, P | 1 |
| Bewtra, AK; Eda, R; Hopp, RJ; Miyagawa, H; Okada, C; Sugiyama, H; Townley, RG | 1 |
| Arnaiz, E; Borja, J; Conde, J; De Molina, M; Izquierdo, I; Martí-Guadaño, E; Martínez-Cócera, C; Pérez, I; Pola, J | 1 |
| Badyal, DK; Johnson, M; Kwatra, G; Thomas, EA | 1 |
2 review(s) available for cetirizine and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
The inhibiting effect of cetirizine 2 HC1 on eosinophil migration and its link to H1 blockade.
Topics: Cetirizine; Chemotaxis, Leukocyte; Eosinophils; Histamine H1 Antagonists; Humans; Hydroxyzine; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Receptors, Histamine H1; Skin | 1991 |
The use of anti-H1 drugs in mild asthma.
Topics: Allergens; Asthma; Bronchoconstriction; Cetirizine; Clinical Trials as Topic; Histamine H1 Antagonists; Humans; Platelet Activating Factor | 1995 |
5 trial(s) available for cetirizine and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
In vivo effects of cetirizine on cutaneous reactivity and eosinophil migration induced by platelet-activating factor (PAF-acether) in man.
Topics: Adult; Cetirizine; Chemotaxis, Leukocyte; Eosinophils; Female; Histamine H1 Antagonists; Humans; Hydroxyzine; Male; Platelet Activating Factor; Skin; Skin Tests | 1990 |
Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin.
Topics: Administration, Oral; Adolescent; Adult; Cetirizine; Eosinophils; Female; Histamine; Histamine H1 Antagonists; Humans; Hydroxyzine; Hypersensitivity, Immediate; Male; Platelet Activating Factor; Skin | 1988 |
Effect of cetirizine, a potent H1 antagonist, on platelet activating factor induced bronchoconstriction in asthma.
Topics: Adult; Airway Resistance; Asthma; Bronchoconstriction; Cetirizine; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Male; Middle Aged; Platelet Activating Factor | 1993 |
Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study.
Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Cetirizine; Child; Cyproheptadine; Double-Blind Method; Female; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Middle Aged; Platelet Activating Factor; Rhinitis, Allergic, Seasonal; Treatment Outcome | 2005 |
Levocetirizine and rupatadine in chronic idiopathic urticaria.
Topics: Adolescent; Adult; Aged; Cetirizine; Child; Chronic Disease; Cyproheptadine; Female; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Middle Aged; Platelet Activating Factor; Quality of Life; Severity of Illness Index; Tumor Necrosis Factor-alpha; Urticaria; Young Adult | 2015 |
11 other study(ies) available for cetirizine and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Interference of cetirizine with the late eosinophil accumulation induced by either PAF or compound 48/80.
Topics: Administration, Topical; Animals; Cetirizine; Chemotactic Factors, Eosinophil; Eosinophilia; Histamine H1 Antagonists; Hydroxyzine; In Vitro Techniques; Male; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Pleurisy; Rats; Rats, Inbred Strains; Time Factors | 1992 |
Suppression by cetirizine of pleurisy triggered by antigen in actively sensitized rats.
Topics: Animals; Antigens; Bradykinin; Cetirizine; Cytoplasmic Granules; Female; Histamine; Histamine H1 Antagonists; Leukocyte Count; Male; Mast Cells; Meclizine; Ovalbumin; Platelet Activating Factor; Pleurisy; Rats; Rats, Wistar; Serotonin | 1992 |
The effect of cetirizine on antigen-dependent leucopenia in the guinea-pig.
Topics: Animals; Benzeneacetamides; Benzhydryl Compounds; Blood Platelets; Cetirizine; Female; Guinea Pigs; Histamine H1 Antagonists; Hydroxamic Acids; Hydroxyzine; In Vitro Techniques; Leukocyte Count; Leukopenia; Leukotriene B4; Lipoxygenase Inhibitors; Male; Platelet Activating Factor; Pyrilamine; Terfenadine | 1991 |
Effects of cetirizine on human eosinophil and neutrophil activation in vitro.
Topics: Animals; Cell Adhesion; Cetirizine; Complement System Proteins; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Eosinophils; Histamine H1 Antagonists; Humans; Hydroxyzine; Immunoglobulin G; In Vitro Techniques; Monocytes; Neutrophils; Platelet Activating Factor; Rosette Formation; Schistosoma mansoni | 1991 |
Platelet-activating factor-induced immediate and late cutaneous reactions.
Topics: Cetirizine; Humans; Hydroxyzine; Platelet Activating Factor; Skin | 1991 |
Effect of cetirizine on cutaneous reactions to PAF, kallikrein and serum in patients with chronic urticaria.
Topics: Adult; Blood Transfusion, Autologous; Cetirizine; Chronic Disease; Female; Histamine; Histamine H1 Antagonists; Humans; Hydroxyzine; Hypersensitivity, Delayed; Injections, Intradermal; Kallikreins; Male; Middle Aged; Platelet Activating Factor; Urticaria | 1990 |
Late-phase cutaneous reactions to platelet activating factor and kallikrein in urticaria.
Topics: Adult; Cetirizine; Chronic Disease; Female; Histamine H1 Antagonists; Humans; Hydroxyzine; Hypersensitivity, Delayed; Injections, Intradermal; Kallikreins; Male; Middle Aged; Platelet Activating Factor; Skin; Urticaria | 1990 |
Inhibition of human eosinophil chemotaxis and of the IgE-dependent stimulation of human blood platelets by cetirizine.
Topics: Blood Platelets; Cetirizine; Chemotaxis, Leukocyte; Chlorpheniramine; Cytotoxicity, Immunologic; Eosinophils; Humans; Hydroxyzine; Hypersensitivity; Immunoglobulin E; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor | 1989 |
Inhibition of eosinophil chemotaxis by a new antiallergic compound (cetirizine).
Topics: Cell Survival; Cells, Cultured; Cetirizine; Chemotaxis, Leukocyte; Chlorpheniramine; Eosinophils; Exocytosis; Humans; Hydroxyzine; In Vitro Techniques; L-Lactate Dehydrogenase; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor | 1988 |
Characterization and pharmacological modulation of antigen-induced peritonitis in actively sensitized mice.
Topics: Animals; Benzeneacetamides; Cetirizine; Cycloheximide; Dexamethasone; Eosinophils; Histamine Release; Hydroxamic Acids; Indomethacin; Kinetics; Leukocyte Count; Leukotriene B4; Leukotriene C4; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Peritoneal Cavity; Peritonitis; Platelet Activating Factor; T-Lymphocytes; Tacrolimus; Terfenadine; Thiazoles; Zymosan | 1993 |
Effect of cetirizine on human eosinophil superoxide generation, eosinophil chemotaxis and eosinophil peroxidase in vitro.
Topics: Adult; Cetirizine; Chemotaxis, Leukocyte; Eosinophil Peroxidase; Eosinophils; Female; Humans; Hypersensitivity; Male; Middle Aged; Peroxidases; Platelet Activating Factor; Superoxides | 1994 |